Csenge Advisory Group’s Stericycle Inc SRCL Stock Holding History

Csenge Advisory Group’s Portfolio SRCL Stock Details SRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-41	Closed	-$1K	–	1569
2018 Q3	$1K	Buy	+41	New	+$2.62K	﹤0.01%	957

Other funds holding SRCL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Csenge Advisory Group's SRCL Position: Q4 2018 in Review

Csenge Advisory Group sold out of Stericycle Inc (SRCL) in Q4 2018, closing a stake of 41 shares — an estimated $1K sold.

Csenge Advisory Group first reported a position in SRCL in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 377 funds tracked by Wall St. Rank hold SRCL as of Q4 2018.

Csenge Advisory Group reported no remaining Stericycle Inc position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 41 Stericycle Inc shares in Q4 2018, an estimated $1K.
Csenge Advisory Group first reported a position in Stericycle Inc in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Stericycle Inc position peaked at $1K in Q3 2018.
377 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.